A study on the immune response, safety and the occurrence of respiratory syncytial virus (RSV)-associated respiratory tract illness after administration of RSV OA vaccine in adults 60 years and older, Trial ID 219815

A study on the immune response, safety and the occurrence of respiratory syncytial virus (RSV)-associated respiratory tract illness after administration of RSV OA vaccine in adults 60 years and older, Trial ID 219815 | GSK